newsfilter
← Latest News
PR Newswire·

Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system

  • The U.S. FDA cleared Medtronic's Hugo RAS system for general surgery procedures via an expanded 510(k).
  • The clearance covers upper abdominal procedures such as cholecystectomy, Roux-en-Y gastric bypass, ventral hernia, & small bowel resection.
  • Lower abdominal procedures including inguinal hernia repair & appendectomy were also approved.
  • These cleared procedures account for approximately 3.5 million surgeries annually in the U.S., representing over half of all soft-tissue procedures performed in the country.
  • General surgery now represents the highest growth for Hugo RAS procedures outside the U.S., surpassing urology & gynecology.
  • Global procedure growth for the Hugo RAS system is running at more than twice the rate of the broader robotic surgery market.
  • The system is projected to surpass 50,000 procedures by the end of Medtronic's fiscal year.
  • The modular design allows surgical teams to utilize only the necessary robotic arms based on the procedure & patient anatomy.
  • The system supports the use of Medtronic's LigaSure RAS Maryland instrument, which has been used in over 45 million open & laparoscopic procedures.
  • The FDA approval expands Hugo RAS capabilities beyond urology to include a wider range of surgical options for U.S. hospitals.
Company
Medtronic plc
Keywords
Medtronic plc